PlainRecalls
FDA Drug Moderate Class II Terminated

ESTRONE USP, packaged in a) 1g bottle (NDC: 58597-8049-2), c) 5g bottle (NDC: 58597-8049-3), d) 25g bottle (NDC: 58597-8049-4), For Prescription Compounding, RX Only, Packed under cGMP conditions by American Pharmaceutical Ingredients, LLC, 6650 Highland Road, Waterford, MI 48327

Reported: June 21, 2017 Initiated: April 17, 2017 #D-0919-2017

Product Description

ESTRONE USP, packaged in a) 1g bottle (NDC: 58597-8049-2), c) 5g bottle (NDC: 58597-8049-3), d) 25g bottle (NDC: 58597-8049-4), For Prescription Compounding, RX Only, Packed under cGMP conditions by American Pharmaceutical Ingredients, LLC, 6650 Highland Road, Waterford, MI 48327

Reason for Recall

cGMP Deviations; lack of quality assurance.

Details

Units Affected
1g=1 bottle; 5g=4 bottle; 25g=3 bottles
Distribution
NY, GA, NV, CA, KY, TX
Location
Waterford, MI

Frequently Asked Questions

What product was recalled?
ESTRONE USP, packaged in a) 1g bottle (NDC: 58597-8049-2), c) 5g bottle (NDC: 58597-8049-3), d) 25g bottle (NDC: 58597-8049-4), For Prescription Compounding, RX Only, Packed under cGMP conditions by American Pharmaceutical Ingredients, LLC, 6650 Highland Road, Waterford, MI 48327. Recalled by American Pharmaceutical Ingredients LLC. Units affected: 1g=1 bottle; 5g=4 bottle; 25g=3 bottles.
Why was this product recalled?
cGMP Deviations; lack of quality assurance.
Which agency issued this recall?
This recall was issued by the FDA Drug on June 21, 2017. Severity: Moderate. Recall number: D-0919-2017.